Raymond Debbane, Director, 10% Owner at LEXICON PHARMACEUTICALS, INC. (LXRX), bought 982,600 shares at $2.50 ($2.5M) on 2022-08-01, disclosed to the SEC on 2022-08-01.
Open-market purchase of $2.5M LXRX by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| Filing → |
| LXRX | BUY | 2026-02-23 | $220K | — | Filing → |
| LXRX | BUY | 2026-02-18 | $353K | — | Filing → |
| LXRX | BUY | 2023-10-12 | $2.2M | — | Filing → |